BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2020 12:00:00 PM | Browse: 1017 | Download: 2176
 |
Received |
|
2019-09-19 04:02 |
|
Peer-Review Started |
|
2019-09-19 04:02 |
|
First Decision by Editorial Office Director |
|
2019-10-18 15:48 |
|
Return for Revision |
|
2019-10-21 07:36 |
|
Revised |
|
2019-12-10 03:07 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-12-21 03:28 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-12-23 17:24 |
|
Articles in Press |
|
2019-12-23 17:24 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-01-18 06:17 |
|
Publish the Manuscript Online |
|
2020-04-15 12:00 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Primary tumor location and survival in colorectal cancer: A retrospective cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Himani Aggarwal, Kristin M Sheffield, Li Li, David Lenis, Rachael Sorg, Afsaneh Barzi and Rebecca Miksad |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Himani Aggarwal, MPhil, PhD, Research Scientist, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46225, United States. aggarwal_himani@lilly.com |
| Key Words |
Bevacizumab; Cetuximab; Cohort study; Colorectal neoplasms; Electronic health records; Prognosis |
| Core Tip |
Primary tumor location is a prognostic factor for metastatic colorectal cancer (mCRC). Post hoc analyses of randomized clinical trials, including FIRE-3 and CALGB/SWOG 80405, suggest that primary tumor location is also predictive of survival benefit with cetuximab and bevacizumab in mCRC patients. This analysis of a large cohort of real-world patients with KRAS wild-type mCRC who received first-line treatment with cetuximab or bevacizumab with 5-fluorouracil-based chemotherapy found a prognostic effect of primary tumor location but not a predictive effect, possibly due to differences between patients in real world clinical practice versus clinical trial settings. |
| Publish Date |
2020-04-15 12:00 |
| Citation |
Aggarwal H, Sheffield KM, Li L, Lenis D, Sorg R, Barzi A, Miksad R. Primary tumor location and survival in colorectal cancer: A retrospective cohort study. World J Gastrointest Oncol 2020; 12(4): 405-423 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i4/405.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i4.405 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
